Brandywine Realty Trust Q2 FY2026 earnings call

• Overall Operational Performance

  • Q2 2026 results met or exceeded the company's business plan, with speculative revenue $1 million above the guidance midpoint
  • Full-year positive net absorption is projected for 2026, the first annual positive absorption in several years
  • Tour volume remained consistent with the elevated levels from Q1 2026, with 53% of tours converting to lease proposals and 41% of proposals converting to signed leases, above historical conversion averages
  • Tenant retention for Q2 hit 85%, leading to an upward revision to full-year retention guidance

• Leasing Activity

  • Total quarterly leasing volume reached 353,000 square feet: 254,000 square feet in the wholly owned portfolio and 98,000 square feet in joint ventures
  • 166,000 square feet of forward leases are scheduled to commence after quarter end, mostly in 2026
  • The overall company leasing pipeline sits just below 2 million square feet, up 13% (220,000 square feet) from Q1, with 456,000 square feet in advanced negotiation stages

• Balance Sheet & Capital Markets Activity

  • $208 million in asset sales have closed to date, with remaining planned sales under contract and scheduled to close in Q3 2026
  • The 3025 JFK construction loan was repaid via a $90 million seven-year secured financing on the residential component of Vera, unencumbering the office component for inclusion in the unencumbered asset pool
  • The company exercised a six-month extension on its existing credit facility, moving maturity to the end of 2026, and is working with its bank group to recast the facility during the extension
  • The paramount capital priority is reducing leverage to return to investment-grade credit metrics; 90-95% of net asset sale proceeds will be used for debt reduction (focused on repurchasing high-coupon bonds, almost 50% of outstanding bonds have coupons above 8.8%), with only 5-10% allocated to opportunistic share buybacks

• Development & Redevelopment Projects

  • One Uptown and 3151 Market Street development pipelines are up more than 10% quarter-over-quarter, with three leases being finalized and five proposals advancing at One Uptown, and a multi-floor tenant in advanced negotiations at 3151 Market Street
  • Planning is underway to redevelop vacated IBM buildings at Uptown ATX starting in 2026, with the first 157,000 square foot renovated building scheduled for delivery in Q4 2027, targeted for an 8%+ cash yield at rents 15-20% below new construction
  • The Radnor Hotel opened on schedule in May 2026, and has already booked 99% of its 2026 full-year projected room nights while hitting its ADR target; full F&B operations will launch by Labor Day 2026, with stabilization targeted for mid-2027

The firm is a commercial real estate REIT focused on office, life science, residential, and hospitality properties, with core operations split across three key geographic segments: 1) Philadelphia CBD/University City: 95% occupied, 97% leased, with 18.3 million yen of speculative revenue that drove full-quarter outperformance; this segment contributed over 54% of all new signed leases, exceeding the company's market share. 2) Pennsylvania Suburbs: 91% overall leased, with the Radnor submarket at 93% leased; the newly stabilized 168,000 square foot 250 King of Prussia Road life science property was added to the core portfolio this quarter, and the newly opened 121-room Radnor Hotel is already outperforming 2026 booking projections. 3) Austin: 67% occupied (excluding the sold 405 Colorado property), lagging the rest of the portfolio and reducing overall company occupancy by more than 400 basis points; the Uptown ATX development pipeline has grown to over 1.1 million square foot ahead of 2027 IBM lease expiration, with planned renovations of the vacated space. Wholly owned portfolio-wide: 90.6% leased, 89.1% occupied, with 88,000 square feet of positive net absorption for the quarter. Second quarter 2026 aggregate financials: Net loss of $31.7 million ($0.18 per share); total FFO of $23.6 million ($0.13 per diluted share), 1 cent below consensus and ahead of prior management guidance. Joint venture FFO contribution was $1.2 million above forecast.

• Full-year 2026 FFO guidance midpoint is maintained at 55 cents per share, with the guidance range narrowed; full-year operating and financial metrics other than tenant retention and asset sales remain unchanged from the original 2026 business plan
• Full-year 2026 asset sale guidance is revised upward to $305 million, from the prior target of $280-$300 million; all $305 million in sales are expected to close by the end of Q3 2026
• Full-year tenant retention guidance is raised to a 51-53% midpoint range, driven by better-than-expected renewals and expansions in Philadelphia CBD and the Pennsylvania suburbs
• Full-year 2026 interest expense guidance is lowered by $6.5 billion at the midpoint to reflect expected lower debt balances from asset sales and debt repayment
• Projected year-end Core Net Debt to EBITDA remains in the 8.0x to 8.4x range, contingent on completion of planned asset sales and recapitalizations
• Third quarter 2026 core FFO is guided to $0.13 to $0.15 per share; Q3 property NOI is expected to be $3 million lower than Q2, driven by the closed sale of 405 Colorado, partially offset by full-quarter contributions from the Radnor Hotel and 250 King of Prussia Road
• Full-year 2026 dividend payout ratio is expected to remain in the 70-90% range, consistent with the business plan

• Austin portfolio occupancy lags core markets, dragging down overall company occupancy by more than 400 basis points; the Austin apartment market faces temporary oversupply that could impact the planned sale of Solaris
• Leasing momentum for life science properties is improving but remains slower than management and market participants desire
• One-time debt extinguishment costs from planned bond repurchases are not included in current FFO guidance and could negatively impact near-term earnings
• Achieving investment-grade credit metrics is dependent on the successful execution of planned asset sales and recapitalizations, which are subject to market conditions
• Leverage ratios will remain elevated until leasing is completed for the company's remaining development projects
• The office conversion pipeline in Philadelphia will take multiple years to impact market fundamentals, with no guarantee of improved pricing or absorption in the near term

Q: Can you provide an update on leasing momentum for 3151 Market Street, particularly for life science tenancy, and have conditions improved for life science over the past 6-9 months? / A: 3151 has a multi-floor tenant in advanced negotiations, and the overall leasing pipeline is up 10% quarter-over-quarter with active touring. Management is seeing a durable positive trend in life science leasing, supported by a new $125 million state financing program for life science companies that is expected to accelerate growth of early-stage tenants moving into larger graduate spaces. While momentum has not grown as fast as desired, the trend line is positive.

Q: What is the reasoning for allocating only 5-10% of asset sale proceeds to share buybacks, rather than a larger allocation? / A: The company's paramount priority is reducing leverage and returning to investment-grade credit metrics. Almost $900 million of outstanding bonds have coupons above 8%, so repurchasing these high-coupon debt delivers far more benefit to credit metrics than share buybacks. The small 5-10% share buyback allocation is opportunistic, given the company believes its stock is undervalued, and does not meaningfully impact deleveraging progress.

Q: After completing the $305 million 2026 asset sale program, will the company continue additional asset sales, and what mix of asset types will be sold? / A: Management expects additional asset sales in the $200 million range over the next 4-6 quarters to continue balance sheet improvement. Future sales will be a mix of stabilized core assets and vacant/value-add assets: the company evaluates each asset via NPV analysis, selling assets where current sale proceeds exceed the projected NPV of holding and stabilizing the asset. Demand is strong from both core institutional buyers (seeking stable long-term leased assets) and returning value-add buyers (willing to take on vacancy risk given improving long-term office fundamentals), with strong bid depth across asset types.

Q: What is the expected total renovation cost for the vacated IBM buildings at Uptown ATX, and what will the company's post-recapitalization ownership stake be for the Austin JV projects? / A: The first 157,000 square foot renovated building will cost approximately $60 million including all infrastructure, base building, and tenant improvement costs, with similar order-of-magnitude costs for additional buildings if renovations move forward. For the planned JV recapitalizations, management targets a final ownership stake of 10-20% (biased toward 10%), with a full sale currently expected for the Solaris residential project to maximize near-term liquidity.